Clinical trial
Bivalirudin in Stable Ischemic Heart Disease Patients Undergoing PCI
NCT02787317 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bivalirudin in Stable Ischemic Heart Disease Patients Undergoing PCI
- Lead sponsor
- Chinese PLA General Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- May 31, 2016
- Completion date
- November 30, 2018
- Enrollment
- 1,770 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.